|
1
|
Albertson DG, Ylstra B, Segraves R,
Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW and Pinkel D:
Quantitative mapping of amplicon structure by array CGH identifies
CYP24 as a candidate oncogene. Nat Genet. 25:144–146. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kallioniemi A, Kallioniemi OP, Piper J,
Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman
FM: Detection and mapping of amplified DNA sequences in breast
cancer by comparative genomic hybridization. Proc Natl Acad Sci
USA. 91:2156–2160. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hodgson JG, Chin K, Collins C and Gray JW:
Genome amplification of chromosome 20 in breast cancer. Breast
Cancer Res Treat. 78:337–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tanner MM, Tirkkonen M, Kallioniemi A,
Holli K, Collins C, Kowbel D, Gray JW, Kallioniemi OP and Isola J:
Amplification of chromosomal region 20q13 in invasive breast
cancer: Prognostic implications. Clin Cancer Res. 1:1455–1461.
1995.PubMed/NCBI
|
|
5
|
Weiss MM, Snijders AM, Kuipers EJ, Ylstra
B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG and Meijer
GA: Determination of amplicon boundaries at 20q13.2 in tissue
samples of human gastric adenocarcinomas by high-resolution
microarray comparative genomic hybridization. J Pathol.
200:320–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deeb KK, Trump DL and Johnson CS: Vitamin
D signalling pathways in cancer: Potential for anticancer
therapeutics. Nat Rev Cancer. 7:684–700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mimori K, Tanaka Y, Yoshinaga K, Masuda T,
Yamashita K, Okamoto M, Inoue H and Mori M: Clinical significance
of the overexpression of the candidate oncogene CYP24 in esophageal
cancer. Ann Oncol. 15:236–241. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parise RA, Egorin MJ, Kanterewicz B, Taimi
M, Petkovich M, Lew AM, Chuang SS, Nichols M, El-Hefnawy T and
Hershberger PA: CYP24, the enzyme that catabolizes the
antiproliferative agent vitamin D, is increased in lung cancer. Int
J Cancer. 119:1819–1828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tannour-Louet M, Lewis SK, Louet JF,
Stewart J, Addai JB, Sahin A, Vangapandu HV, Lewis AL, Dittmar K,
Pautler RG, et al: Increased expression of CYP24A1 correlates with
advanced stages of prostate cancer and can cause resistance to
vitamin D3-based therapies. FASEB J. 28:364–372. 2014.
View Article : Google Scholar
|
|
10
|
Townsend K, Banwell CM, Guy M, Colston KW,
Mansi JL, Stewart PM, Campbell MJ and Hewison M: Autocrine
metabolism of vitamin D in normal and malignant breast tissue. Clin
Cancer Res. 11:3579–3586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masuda S, Kaufmann M, Byford V, Gao M,
St-Arnaud R, Arabian A, Makin HL, Knutson JC, Strugnell S and Jones
G: Insights into Vitamin D metabolism using cyp24 over-expression
and knockout systems in conjunction with liquid chromatography/mass
spectrometry (LC/MS). J Steroid Biochem Mol Biol. 89–90:149–153.
2004. View Article : Google Scholar
|
|
12
|
Vanoirbeek E, Eelen G, Verlinden L,
Carmeliet G, Mathieu C, Bouillon R, O'Connor R, Xiao G and Verstuyf
A: PDLIM2 expression is driven by vitamin D and is involved in the
proadhesion, and anti-migration and -invasion activity of vitamin
D. Oncogene. 33:1904–1911. 2014. View Article : Google Scholar
|
|
13
|
Cao Z, West C, Norton-Wenzel CS and Rej R,
Davis FB, Davis PJ and Rej R: Effects of resin or charcoal
treatment on fetal bovine serum and bovine calf serum. Endocr Res.
34:101–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwartz GG and Blot WJ: Vitamin D status
and cancer incidence and mortality: Something new under the sun. J
Natl Cancer Inst. 98:428–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spina CS, Tangpricha V, Uskokovic M,
Adorinic L, Maehr H and Holick MF: Vitamin D and cancer. Anticancer
Res. 26A:2515–2524. 2006.
|
|
16
|
Lopes N, Sousa B, Martins D, Gomes M,
Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL and Schmitt
F: Alterations in Vitamin D signalling and metabolic pathways in
breast cancer progression: A study of VDR, CYP27B1 and CYP24A1
expression in benign and malignant breast lesions. BMC Cancer.
10:4832010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Höbaus J, Hummel DM, Thiem U, Fetahu IS,
Aggarwal A, Müllauer L, Heller G, Egger G, Mesteri I,
Baumgartner-Parzer S, et al: Increased copy-number and not DNA
hypomethylation causes overexpression of the candidate
proto-oncogene CYP24A1 in colorectal cancer. Int J Cancer.
133:1380–1388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tashiro K, Ishii C and Ryoji M: Role of
distal upstream sequence in vitamin D-induced expression of human
CYP24 gene. Biochem Biophys Res Commun. 358:259–265. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pike JW and Meyer MB: Regulation of mouse
Cyp24a1 expression via promoter-proximal and downstream-distal
enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3)
action. Arch Biochem Biophys. 523:2–8. 2012. View Article : Google Scholar
|
